Inviting an author to review:
Find an author and click ‘Invite to review selected article’ near their name.
Search for authorsSearch for similar articles
44
views
0
recommends
+1 Recommend
2 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      A Chronicle of SARS-CoV-2: Seasonality, Environmental Fate, Transport, Inactivation, and Antiviral Drug Resistance

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          In this review, we present the environmental perspectives of the viruses and antiviral drugs related to SARS-CoV-2. The present review paper discusses occurrence, fate, transport, susceptibility, and inactivation mechanisms of viruses in the environment as well as environmental occurrence and fate of antiviral drugs, and prospects (prevalence and occurrence) of antiviral drug resistance (both antiviral drug resistant viruses and antiviral resistance in the human). During winter, the number of viral disease cases and environmental occurrence of antiviral drug surge due to various biotic and abiotic factors such as transmission pathways, human behaviour, susceptibility, and immunity as well as cold climatic conditions. Adsorption and persistence critically determine the fate and transport of viruses in the environment. Inactivation and disinfection of virus include UV, alcohol, chemical-base methods but the susceptibility of virus against these methods varies. Wastewater treatment plants (WWTPs) are major sources of antiviral drugs and their metabolites and transformation products. Ecotoxicity of antiviral drug residues against aquatic organisms have been reported, however more threatening is the development of antiviral resistance, both in humans and in wild animal reservoirs. In particular, emergence of antiviral drug-resistant viruses via exposure of wild animals to high loads of antiviral residues during the current pandemic needs further evaluation.

          Graphical Abstract

          HIGHLIGHTS

          • We analysed environmental perspectives of antiviral drugs and SARS-CoV-2.

          • Susceptibility and inactivation causes seasonality in the prevalence of SARS-CoV-2.

          • Surface-charge interactions govern environmental fate and transport of SARS-CoV-2.

          • Unprecedented use of antiviral drugs is hazardous to the environment.

          • Emergence of antiviral drug-resistant viruses needs further investigations.

          Related collections

          Most cited references150

          • Record: found
          • Abstract: found
          • Article: found

          Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China

          In December 2019, novel coronavirus (2019-nCoV)-infected pneumonia (NCIP) occurred in Wuhan, China. The number of cases has increased rapidly but information on the clinical characteristics of affected patients is limited.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents

            Summary Currently, the emergence of a novel human coronavirus, SARS-CoV-2, has become a global health concern causing severe respiratory tract infections in humans. Human-to-human transmissions have been described with incubation times between 2-10 days, facilitating its spread via droplets, contaminated hands or surfaces. We therefore reviewed the literature on all available information about the persistence of human and veterinary coronaviruses on inanimate surfaces as well as inactivation strategies with biocidal agents used for chemical disinfection, e.g. in healthcare facilities. The analysis of 22 studies reveals that human coronaviruses such as Severe Acute Respiratory Syndrome (SARS) coronavirus, Middle East Respiratory Syndrome (MERS) coronavirus or endemic human coronaviruses (HCoV) can persist on inanimate surfaces like metal, glass or plastic for up to 9 days, but can be efficiently inactivated by surface disinfection procedures with 62–71% ethanol, 0.5% hydrogen peroxide or 0.1% sodium hypochlorite within 1 minute. Other biocidal agents such as 0.05–0.2% benzalkonium chloride or 0.02% chlorhexidine digluconate are less effective. As no specific therapies are available for SARS-CoV-2, early containment and prevention of further spread will be crucial to stop the ongoing outbreak and to control this novel infectious thread.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              The FDA-approved Drug Ivermectin inhibits the replication of SARS-CoV-2 in vitro

              Although several clinical trials are now underway to test possible therapies, the worldwide response to the COVID-19 outbreak has been largely limited to monitoring/containment. We report here that Ivermectin, an FDA-approved anti-parasitic previously shown to have broad-spectrum anti-viral activity in vitro, is an inhibitor of the causative virus (SARS-CoV-2), with a single addition to Vero-hSLAM cells 2 hours post infection with SARS-CoV-2 able to effect ∼5000-fold reduction in viral RNA at 48 h. Ivermectin therefore warrants further investigation for possible benefits in humans.
                Bookmark

                Author and article information

                Journal
                J Hazard Mater
                J Hazard Mater
                Journal of Hazardous Materials
                Elsevier B.V.
                0304-3894
                1873-3336
                6 October 2020
                6 October 2020
                : 124043
                Affiliations
                [a ]Discipline of Earth Science, Indian Institute of Technology Gandhinagar, Gujarat 382 355, India
                [b ]Centre for the Environment, Indian Institute of Technology Guwahati, Guwahati, Assam 781039, India
                [c ]Environmnetal Science and Engineering Department, Indian Institute of Technology Bombay, Mumbai 400076 India
                [d ]Discipline of Civil Engineering, Indian Institute of Technology Gandhinagar, Gujarat 382 355, India
                [e ]Department of Sustainable Development, Environmental Science and Engineering, KTH Royal Institute of Technology, Teknikringen 10B, SE-10044 Stockholm, Sweden
                [f ]Laboratory of Soil- and Groundwater-Management, School of Architecture and Civil Engineering, University of Wuppertal, Wuppertal 42285, Germany
                [g ]Department of Environment, Energy and Geoinformatics, University of Sejong, Seoul, Republic of Korea
                [h ]Division of Environmental Engineering, Hokkaido University, Hokkaido 060-8628, Japan
                [i ]Faculty of Engineering and Information Sciences, University of Wollongong, Australia
                [j ]Department of Civil Engineering, King Saud University, Riyadh
                [k ]Research Centre for Water Environment Technology, Graduate School of Engineering, The University of Tokyo, Tokyo 113-8656, Japan
                [l ]Department of Bioscience, Aarhus University, Frederiksborgvej 399, PO Box 358, DK-4000 Roskilde, Denmark
                [m ]Department of Environmental and Civil Engineering, Toyama Prefectural University, Toyama 9390398, Japan
                Author notes
                [* ]Correspondence to: Discipline of Earth Sciences | Room No. 336A, Block 5| Indian Institute of Technology Gandhinagar-382355, Gujarat, INDIA.
                Article
                S0304-3894(20)32033-1 124043
                10.1016/j.jhazmat.2020.124043
                7536132
                33268203
                3786faf2-d8fe-408c-b1c2-89a767f3dcf7
                © 2020 Elsevier B.V. All rights reserved.

                Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.

                History
                : 22 June 2020
                : 11 September 2020
                : 17 September 2020
                Categories
                Article

                coronavirus,covid-19,water,antiviral drugs,antiviral resistance,sars-cov-2

                Comments

                Comment on this article